COVID-19

For the first time, a study found a link between the COVID-19 pandemic’s impact on family finances and children’s mental health, researchers reported.

The FDA’s Antimicrobial Drugs Advisory Committee voted Thursday to support the approval of Paxlovid for the treatment of mild-to-moderate COVID-19 in adults at high risk for severe disease, hospitalization or death.

SAN ANTONIO — Patients with asthma in an inner-city population had more favorable COVID-19 outcomes than patients who did not have asthma, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Patients diagnosed with COVID-19 during the first 3 months of the pandemic had a twofold higher risk for developing alcohol use disorder, likely driven by anxiety and fear surrounding the pandemic, according to new research.

SAN ANTONIO — Patients taking biologics for severe asthma experienced COVID-19 than those who were not taking biologics, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Patients with systemic lupus erythematosus who are vaccinated for COVID-19 demonstrate reduced antibody levels compared with vaccinated controls, according to data published in Arthritis Care & Research.

The COVID-19 pandemic increased risk for negative cardiac surgery outcomes, but socioeconomic status did not significantly affect surgical outcomes during the pandemic, researchers reported.

An analysis of COVID-19 outcomes among people being treated for HIV or taking PrEP for HIV prevention found that the HIV medication tenofovir was associated with a lower rate of clinical events, suggesting a protective effect.

Around one-quarter of surveyed parents reported not adhering to a public health measures against COVID-19.